跳至主要内容
临床试验/NCT02406703
NCT02406703已完成不适用

Can the Choice of the Local Anesthetic Have an Impact on Ambulatory Surgery Perioperative Costs? Chloroprocaine for Popliteal Block in Outpatient Foot Surgery

Ospedale Regionale Bellinzona e Valli0 个研究点目标入组 100 人开始时间: 2014年1月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
100
主要终点
Cost minimization analysis

研究概览

简要总结

Background and Objectives Short acting regional anesthetics have already been successfully employed for peripheral nerve blocks in an ambulatory surgery setting. However, the impact on direct and indirect perioperative costs comparing two different short-acting local anesthetics has not been performed, yet.

Methods In an observational study including 50 patients per group, patient undergoing popliteal block with chloroprocaine 3% or mepivacaine 1.5% for ambulatory minor foot surgery were compared. The primary outcome was the saving of both direct and indirect perioperative costs. Secondary outcomes were block success, onset time and block duration, patient satisfaction and unplanned outpatient visits or readmissions after discharge.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ASA I-III scheduled for elective, unilateral, ambulant minor foot surgery (percutaneous hallux valgus correction, osteotomies, tenotomies, mallet and hammer toes correction, screws and/or plaques removal)

排除标准

  • known allergy to drugs used in the study;
  • coagulopathies, known neuropathy;
  • pregnancy;
  • chronic pain;
  • drug or alcohol abuse;
  • psychiatric disease or lack of competence affecting compliance and evidence of ongoing sepsis or local skin / subcutaneous tissues infections in the popliteal fossa.

研究组 & 干预措施

Chloroprocaine

Patient undergoing popliteal block with chloroprocaine

干预措施: Chloroprocaine (Drug)

Mepivacaine

Patient undergoing popliteal block with mepivacaine

干预措施: Mepivacaine (Drug)

结局指标

主要结局

Cost minimization analysis

时间窗: 6 months

次要结局

未报告次要终点

研究者

发起方
Ospedale Regionale Bellinzona e Valli
申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrea Saporito

MD

Ospedale Regionale Bellinzona e Valli

相似试验